Business
Press Release Jan 28 2025
Cipla Limited has informed the Exchange regarding a press release dated January 28, 2025, titled "Press Release Q3FY25".
About this update from Cipla Ltd
Cipla Limited has informed the Exchange regarding a press release dated January 28, 2025, titled "Press Release Q3FY25". View Attachment
More from Cipla Ltd
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda in the US
September 4, 2026
Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in...
September 3, 2026